Lizheng Shi - Search Results

Year	Number of Results
2002	1
2003	2
2004	4
2005	3
2006	3
2007	4
2008	2
2009	7
2010	13
2011	6
2012	10
2013	10
2014	10
2015	17
2016	10
2017	10
2018	20
2019	24
2020	41
2021	28
2022	20
2023	24
2024	9

1

Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma.

Su D, Wu B, Shi L. Su D, et al. Among authors: shi l. JAMA Netw Open. 2021 Feb 1;4(2):e210037. doi: 10.1001/jamanetworkopen.2021.0037. JAMA Netw Open. 2021. PMID: 33625508 Free PMC article.

2

How health technology reassessment can support disinvestment in China's national drug reimbursement list.

Shi L, Wu J, Meng Q, Li D. Shi L, et al. BMJ. 2023 Jun 15;381:e068917. doi: 10.1136/bmj-2021-068917. BMJ. 2023. PMID: 37321624 Free PMC article.

3

5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine.

Niu S, Alkhuzam KA, Guan D, Jiao T, Shi L, Fonseca V, Laiteerapong N, Ali MK, Schatz DA, Guo J, Shao H. Niu S, et al. Among authors: shi l. Diabetes Obes Metab. 2024 Feb;26(2):463-472. doi: 10.1111/dom.15332. Epub 2023 Oct 22. Diabetes Obes Metab. 2024. PMID: 37867175 Clinical Trial.

4

Development of health technology assessment in China: New challenges.

Chen Y, He Y, Chi X, Wei Y, Shi L. Chen Y, et al. Among authors: shi l. Biosci Trends. 2018;12(2):102-108. doi: 10.5582/bst.2018.01038. Biosci Trends. 2018. PMID: 29760354 Free article. Review.

5

Filling the Public Health Science Gaps for Diabetes With Natural Experiments.

Gregg EW, Duru OK, Shi L, Mangione CM, Siegel KR, Ramsay A, Thornton PL, Clauser S, Ali MK. Gregg EW, et al. Among authors: shi l. Med Care. 2020 Jun;58 Suppl 6 Suppl 1:S1-S3. doi: 10.1097/MLR.0000000000001330. Med Care. 2020. PMID: 32412947 No abstract available.

6

Medication Adherence: Expanding the Conceptual Framework.

Krousel-Wood M, Craig LS, Peacock E, Zlotnick E, O'Connell S, Bradford D, Shi L, Petty R. Krousel-Wood M, et al. Among authors: shi l. Am J Hypertens. 2021 Sep 22;34(9):895-909. doi: 10.1093/ajh/hpab046. Am J Hypertens. 2021. PMID: 33693474 Free PMC article.

7

Economic burden of diabetes-related hypoglycemia on patients, payors, and employers.

Shi L, Fonseca V, Childs B. Shi L, et al. J Diabetes Complications. 2021 Jun;35(6):107916. doi: 10.1016/j.jdiacomp.2021.107916. Epub 2021 Mar 22. J Diabetes Complications. 2021. PMID: 33836965 Review.

8

Cervical Cancer Mortality in Younger Women.

Zhou P, Chen D, Shi L. Zhou P, et al. Among authors: shi l. J Gen Intern Med. 2020 Feb;35(2):592. doi: 10.1007/s11606-019-05183-4. J Gen Intern Med. 2020. PMID: 31346905 Free PMC article. No abstract available.

9

Affordable Care Act and Diabetes Mellitus.

Shi Q, Nellans FP, Shi L. Shi Q, et al. Among authors: shi l. Curr Diab Rep. 2015 Dec;15(12):106. doi: 10.1007/s11892-015-0679-1. Curr Diab Rep. 2015. PMID: 26458377 Review.

10

The Association Between Baseline Insulin Treatment and Cardiovascular Events: A Meta-Analysis.

Khatib JE, Shao Y, Shi L, Fonseca VA. Khatib JE, et al. Among authors: shi l. J Endocr Soc. 2020 Dec 31;5(2):bvaa193. doi: 10.1210/jendso/bvaa193. eCollection 2021 Feb 1. J Endocr Soc. 2020. PMID: 33447691 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

242 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Results by year